GB9007569D0 - Carbo-nucleoside derivatives - Google Patents
Carbo-nucleoside derivativesInfo
- Publication number
- GB9007569D0 GB9007569D0 GB909007569A GB9007569A GB9007569D0 GB 9007569 D0 GB9007569 D0 GB 9007569D0 GB 909007569 A GB909007569 A GB 909007569A GB 9007569 A GB9007569 A GB 9007569A GB 9007569 D0 GB9007569 D0 GB 9007569D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- carbo
- nucleoside derivatives
- nucleoside
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909007569A GB9007569D0 (en) | 1990-04-04 | 1990-04-04 | Carbo-nucleoside derivatives |
| PCT/EP1991/000655 WO1991015488A1 (en) | 1990-04-04 | 1991-04-04 | Carbo-nucleoside derivatives |
| CA002079815A CA2079815A1 (en) | 1990-04-04 | 1991-04-04 | Carbo-nucleoside derivatives |
| AU76959/91A AU7695991A (en) | 1990-04-04 | 1991-04-04 | Carbo-nucleoside derivatives |
| EP91907828A EP0523160A1 (en) | 1990-04-04 | 1991-04-04 | Carbo-nucleoside derivatives |
| JP91507691A JPH05507267A (en) | 1990-04-04 | 1991-04-04 | Carbonucleoside derivatives |
| OA60272A OA09670A (en) | 1990-04-04 | 1992-09-11 | Carbo-nucleoside derivatives |
| NO92923848A NO923848L (en) | 1990-04-04 | 1992-10-02 | KARBO-nucleoside derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909007569A GB9007569D0 (en) | 1990-04-04 | 1990-04-04 | Carbo-nucleoside derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9007569D0 true GB9007569D0 (en) | 1990-05-30 |
Family
ID=10673843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB909007569A Pending GB9007569D0 (en) | 1990-04-04 | 1990-04-04 | Carbo-nucleoside derivatives |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0523160A1 (en) |
| JP (1) | JPH05507267A (en) |
| AU (1) | AU7695991A (en) |
| CA (1) | CA2079815A1 (en) |
| GB (1) | GB9007569D0 (en) |
| OA (1) | OA09670A (en) |
| WO (1) | WO1991015488A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0630897A3 (en) * | 1993-06-25 | 1995-03-01 | Bristol Myers Squibb Co | 3-Hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines. |
| AU2787199A (en) * | 1998-02-25 | 1999-09-15 | Emory University | 2'-fluoronucleosides |
| AU7653300A (en) * | 1999-09-10 | 2001-04-10 | Stichting Rega Vzw | Carbocyclic nucleosides and process for obtaining such |
| KR100905221B1 (en) | 2000-10-18 | 2009-07-01 | 파마셋 인코포레이티드 | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| CA2463719A1 (en) | 2003-04-05 | 2004-10-05 | F. Hoffmann-La Roche Ag | Nucleotide analogs with six membered rings |
| MX2010000424A (en) | 2007-07-09 | 2010-08-10 | Easter Virginia Medical School | Substituted nucleoside derivatives with antiviral and antimicrobial properties. |
| EP2445343B1 (en) | 2009-06-25 | 2021-08-04 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds |
| JP7384812B2 (en) | 2018-03-05 | 2023-11-21 | アルカームス ファーマ アイルランド リミテッド | Aripiprazole dosing strategy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51332B1 (en) * | 1980-06-23 | 1986-12-10 | Univ Minnesota | Novel adenine nucleoside derivatives,their preparation and pharmaceutical compositions containing them |
| US4396623A (en) * | 1981-08-26 | 1983-08-02 | Southern Research Institute | Carbocyclic analogs of uracil nucleosides as antiviral agents |
| US4719214A (en) * | 1985-07-25 | 1988-01-12 | Southern Research Institute | Carbocyclic analogues of thymine nucleosides |
| WO1988007532A1 (en) * | 1987-03-24 | 1988-10-06 | Nycomed A.S. | 2',3' dideoxyribofuranoxide derivatives |
| US5015739A (en) * | 1988-04-22 | 1991-05-14 | Schering Corporation | Processes for preparation of cyclopentyl purine derivatives |
-
1990
- 1990-04-04 GB GB909007569A patent/GB9007569D0/en active Pending
-
1991
- 1991-04-04 WO PCT/EP1991/000655 patent/WO1991015488A1/en not_active Ceased
- 1991-04-04 JP JP91507691A patent/JPH05507267A/en active Pending
- 1991-04-04 EP EP91907828A patent/EP0523160A1/en not_active Withdrawn
- 1991-04-04 AU AU76959/91A patent/AU7695991A/en not_active Abandoned
- 1991-04-04 CA CA002079815A patent/CA2079815A1/en not_active Abandoned
-
1992
- 1992-09-11 OA OA60272A patent/OA09670A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2079815A1 (en) | 1991-10-05 |
| AU7695991A (en) | 1991-10-30 |
| EP0523160A1 (en) | 1993-01-20 |
| OA09670A (en) | 1993-05-15 |
| WO1991015488A1 (en) | 1991-10-17 |
| JPH05507267A (en) | 1993-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0440950A3 (en) | Halogenallyl-azolyl derivatives | |
| HU912356D0 (en) | Rapacmycine derivatives | |
| ZA916098B (en) | Oxazolidinodione derivatives | |
| EP0470466A3 (en) | Halogenalkyl-azolyl derivatives | |
| ZA914484B (en) | Azolyl-propanol derivatives | |
| IL96819A0 (en) | Azaoxindole derivatives | |
| LTIP848A (en) | Hiv-inhibiting benzene-acetamide derivatives | |
| IL99576A0 (en) | Triazacyclohexane derivatives | |
| EP0438690A3 (en) | Substituted pyrazolin derivatives | |
| EP0485984A3 (en) | Diarylmethoxypiperidine derivatives | |
| ZA914204B (en) | Pyridinylpiperazine derivatives | |
| ZA916254B (en) | Halogenoalkyl-azolyl derivatives | |
| AP9100308A0 (en) | Carboxymethylcyclopropane derivatives | |
| EP0520435A3 (en) | Dc-89 derivatives | |
| OA09670A (en) | Carbo-nucleoside derivatives | |
| EP0440949A3 (en) | Halogenallyl-azolyl derivatives | |
| ZA914675B (en) | 5-isothiazolamine derivatives | |
| EP0453883A3 (en) | 2-amino-4-trichloropyridine derivatives | |
| GB2249094B (en) | Hetero-imidazodiazepine derivatives | |
| EP0449346A3 (en) | 4-piperidinyl-ergoline derivatives | |
| EG19474A (en) | Nitroenamine derivatives | |
| EG19362A (en) | Azoaxindole derivatives | |
| IE901338L (en) | Carbamoyl-indole derivatives | |
| ZA914804B (en) | Antimigrine alkoxypyrimidine derivatives | |
| NZ240842A (en) | 4-phenoxy- and 4-pyridoxy-benzaldehyde derivatives |